- Home
- PYPD vs NTIP Comparison
PYPD vs NTIP Comparison
Compare PYPD & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- NTIP
- Stock Information
- Founded
- PYPD 2008
- NTIP 1990
- Country
- PYPD Israel
- NTIP United States
- Employees
- PYPD N/A
- NTIP N/A
- Industry
- PYPD Medical/Dental Instruments
- NTIP Multi-Sector Companies
- Sector
- PYPD Health Care
- NTIP Miscellaneous
- Exchange
- PYPD Nasdaq
- NTIP Nasdaq
- Market Cap
- PYPD 30.1M
- NTIP 31.9M
- IPO Year
- PYPD 2020
- NTIP 1998
- Fundamental
- Price
- PYPD $2.75
- NTIP $1.33
- Analyst Decision
- PYPD Strong Buy
- NTIP
- Analyst Count
- PYPD 2
- NTIP 0
- Target Price
- PYPD $10.50
- NTIP N/A
- AVG Volume (30 Days)
- PYPD 14.1K
- NTIP 8.4K
- Earning Date
- PYPD 05-07-2025
- NTIP 05-09-2025
- Dividend Yield
- PYPD N/A
- NTIP 7.63%
- EPS Growth
- PYPD N/A
- NTIP N/A
- EPS
- PYPD N/A
- NTIP N/A
- Revenue
- PYPD N/A
- NTIP $100,000.00
- Revenue This Year
- PYPD N/A
- NTIP N/A
- Revenue Next Year
- PYPD N/A
- NTIP N/A
- P/E Ratio
- PYPD N/A
- NTIP N/A
- Revenue Growth
- PYPD N/A
- NTIP N/A
- 52 Week Low
- PYPD $2.37
- NTIP $1.22
- 52 Week High
- PYPD $5.09
- NTIP $2.13
- Technical
- Relative Strength Index (RSI)
- PYPD 42.15
- NTIP 40.96
- Support Level
- PYPD $2.66
- NTIP $1.30
- Resistance Level
- PYPD $2.97
- NTIP $1.39
- Average True Range (ATR)
- PYPD 0.14
- NTIP 0.05
- MACD
- PYPD -0.02
- NTIP -0.00
- Stochastic Oscillator
- PYPD 8.86
- NTIP 30.77
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.